Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene

Endocrine Journal

Volumn 56, Issue 2, 2009, Pages 221-225

  Pérez Castrillón, Jose Luis ^a   Vega, Gemma ^a   Abad, Laura ^a   Sanz Cantalapiedra, Alberto ^a   Sagredo, Manuel Gonzalez ^a   De Luis, Daniel ^a   Duenas Laita, Antonio ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Atorvastatin; Coronary syndrome; Leptin; Lys658asn polymorphism

Indexed keywords

ASPARAGINE; ATORVASTATIN; CALCIUM; CHOLESTEROL; DEOXYPYRIDINOLINE; LEPTIN RECEPTOR; LYSINE; MAGNESIUM; OSTEOCALCIN; PHOSPHORUS; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE REMODELING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GENOTYPE; HETEROZYGOSITY; HIP DISEASE; HOMOZYGOSITY; HUMAN; LOW DRUG DOSE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREVALENCE; RECEPTOR GENE; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE CORONARY SYNDROME; AGED; BONE DENSITY; BONE REMODELING; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; PYRROLES; RECEPTORS, LEPTIN;

EID: 66849106733     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-269     Document Type: Article

References (18)

1. Perez-Castrillon JL, De Luis D, Duenas-Laita A (2008) Atherosclerosis and osteoporosis. Minerva Med 99: 45-54.
2. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695.
3. Pacifici R (1996) Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11: 1043-1051.
4. Perez Castrillon JL, Abad L, Vega G, Sanz- Cantalapiedra A, Sanchez S, Hernandez G, et al. (2006) Effects of statins on bone markers, bone mineral density and fractures. Possible role in osteoporosis treatment. Cur Pharm Anal 2: 161-168.
5. Karsenty G (2006) Convergence between bone and energy homeostases: review leptin regulation of bone mass. Cell Metabolism 4: 341-348.
6. Beltowski J (2006) Leptin and atherosclerosis. Atherosclerosis 189: 47-60.
7. Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F, Sert Kuniyoishi FH, Wolk R, Somers VK (2007) Relation of increased leptin concentration to history of my- ocardial infarction and stroke in the US population. Am J Cardiol 100: 234-239.
8. Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Chihara K (2001) Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol 55: 341-347.
9. Weiss L, Barrett-Connor E, Von Muhlen D, Clark P (2006) Leptin predicts BMD and one resorption in older women but not older men: the Rancho -Bernardo Study. J Bone Miner Res 21: 758-764.
10. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110: 227-239.
11. Hamrick MW, Ferrari SL (2008) Leptin and the sympathetic connection of fat to bone. Osteoporos Int 19:905-912.
12. Fairbrother UL, Tanko LB, Walley AJ, Christiansen C, Froguel P, Blakemore AIF (2007) Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J Bone Miner Res 22: 544-550.
13. Seibel MJ (2005) Biochemical markers of bone turnover: Part I. Biochemistry and variability. Clin Bio- chem Rev 26: 97-122.
14. De Luis Roman D, Aller de la Fuente R, Gonzalez Sagrado M, Izaola O, Conde Vicente R (2006) Leptin receptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch Med Res 37: 854-859.
15. VanPatten S, Ranginami N, Shefer S, Nguyen LB, Rossetti L, Cohen DE (2001) Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest. Liver Physiol 281: G393-G404.
16. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Miiller C, Carling D, et al. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343.
17. Ferrer A, Caelles C, Massot N, Hegardt FG (1985) Activation of rat liver cytosolic 3-hydroxy-3-methylglu- taryl coenzyme A reductase kinase by adenosine 5'- monophosphate. Biochem Biophys Res Commun 132: 497-504.
18. Takahashi-Yasuno A, Masuzaki H, Miyawaki T, Oga- wa Y, Matsuoka N, Hayashi T, et al. (2003) Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men. Diabet Res Clin Pract 62: 169-175.